Lodaat Pharma

LODAAT Pharma is a US firm with a portfolio of innovative, high-value molecules spanning biosimilars, biologics, rare disease and orphan drugs. Its consumer health group is renowned for innovation in OTC products across major therapeutic categories including pain management, inflammation and gut microbiome, and the company is a leading investor in new chemical entity and new drug development for oncology, cognition, cardiovascular and other therapeutic areas, seeking leading global partners who share its vision for cutting-edge therapeutics.